N-of-One Therapeutics, Inc. provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.

N-of-One Therapeutics, Inc. provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.

Increasing Accessibility to Personalized Cancer Treatment Options - Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. Massive Bio translates the world-class oncology knowledge of the large cancer centers'​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost.

Increasing Accessibility to Personalized Cancer Treatment Options - Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. Massive Bio translates the world-class oncology knowledge of the large cancer centers'​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost.